Small molecule inhibitors of signal transducer and activator of transcription 3 (stat3) protein

Journal of Medicinal Chemistry

Volumn 55, Issue 15, 2012, Pages 6645-6648

  Debnath, Bikash ^a   Xu, Shili ^a   Neamati, Nouri ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIHYDROXYBENZENESULFONIC ACID; 515 DPP; AURANOFIN; BETULIC ACID; BUTEIN(3,4,2',4' TETRAHYDROXYCHALCONE; CAPSAICIN; CELECOXIB; CRYPTOTANSHINONE; CURCUMIN; FLLL 11; FLLL 12; FLLL 31; FLLL 32; GUGGULSTERONE; ISS 610; LLL 12; LLL 3; NIFUROXAZIDE; PROTEIN INHIBITOR; PYRIMETHAMINE; QUINOLINE DERIVATIVE; QUINOLINONE DERIVATIVE; S 31201; SILIBININ; STA 21; STAT3 PROTEIN; STX 0119; TETRANGOMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CRYSTAL STRUCTURE; ENTERITIS; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; LYMPHATIC LEUKEMIA; MOLECULAR LIBRARY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN STRUCTURE; PSORIASIS; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; DRUG DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NEOPLASMS; PEPTIDES; PEPTIDOMIMETICS; PSORIASIS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84864917825     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300207s     Document Type: Review

References (172)

1. Yu, H.; Pardoll, D.; Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3 Nat. Rev. Cancer 2009, 9, 798-809
2. Boengler, K.; Hilfiker-Kleiner, D.; Drexler, H.; Heusch, G.; Schulz, R. The myocardial JAK/STAT pathway: from protection to failure Pharmacol. Ther. 2008, 120, 172-185
3. Akira, S.; Nishio, Y.; Inoue, M.; Wang, X. J.; Wei, S.; Matsusaka, T.; Yoshida, K.; Sudo, T.; Naruto, M.; Kishimoto, T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway Cell 1994, 77, 63-71
4. Zhong, Z.; Wen, Z.; Darnell, J. E., Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 Science 1994, 264, 95-98
5. Hevehan, D. L.; Miller, W. M.; Papoutsakis, E. T. Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation Blood 2002, 99, 1627-1637
6. Chakraborty, A.; Tweardy, D. J. Stat3 and G-CSF-induced myeloid differentiation Leuk. Lymphoma 1998, 30, 433-442
7. Caldenhoven, E.; van Dijk, T. B.; Solari, R.; Armstrong, J.; Raaijmakers, J. A.; Lammers, J. W.; Koenderman, L.; de Groot, R. P. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription J. Biol. Chem. 1996, 271, 13221-13227
8. Maritano, D.; Sugrue, M. L.; Tininini, S.; Dewilde, S.; Strobl, B.; Fu, X.; Murray-Tait, V.; Chiarle, R.; Poli, V. The STAT3 isoforms alpha and beta have unique and specific functions Nat. Immunol. 2004, 5, 401-409
9. Chakraborty, A.; Tweardy, D. J. Granulocyte colony-stimulating factor activates a 72-kDa isoform of STAT3 in human neutrophils J. Leukocyte Biol. 1998, 64, 675-680
10. Becker, S.; Groner, B.; Muller, C. W. Three-dimensional structure of the Stat3beta homodimer bound to DNA Nature 1998, 394, 145-151
11. Ren, Z.; Mao, X.; Mertens, C.; Krishnaraj, R.; Qin, J.; Mandal, P. K.; Romanowski, M. J.; McMurray, J. S.; Chen, X. Crystal structure of unphosphorylated STAT3 core fragment Biochem. Biophys. Res. Commun. 2008, 374, 1-5
12. Nelson, K. L.; Rogers, J. A.; Bowman, T. L.; Jove, R.; Smithgall, T. E. Activation of STAT3 by the c-Fes protein-tyrosine kinase J. Biol. Chem. 1998, 273, 7072-7077
13. Yu, H.; Kortylewski, M.; Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat. Rev. Immunol. 2007, 7, 41-51
14. Yokogami, K.; Wakisaka, S.; Avruch, J.; Reeves, S. A. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR Curr. Biol. 2000, 10, 47-50
15. Aznar, S.; Valeron, P. F.; del Rincon, S. V.; Perez, L. F.; Perona, R.; Lacal, J. C. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation Mol. Biol. Cell 2001, 12, 3282-3294
16. Yuan, Z. L.; Guan, Y. J.; Chatterjee, D.; Chin, Y. E. Stat3 dimerization regulated by reversible acetylation of a single lysine residue Science 2005, 307, 269-273
17. Giraud, S.; Bienvenu, F.; Avril, S.; Gascan, H.; Heery, D. M.; Coqueret, O. Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a J. Biol. Chem. 2002, 277, 8004-8011
18. Gray, M. J.; Zhang, J.; Ellis, L. M.; Semenza, G. L.; Evans, D. B.; Watowich, S. S.; Gallick, G. E. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas Oncogene 2005, 24, 3110-3120
19. Zhang, X.; Wrzeszczynska, M. H.; Horvath, C. M.; Darnell, J. E., Jr. Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation Mol. Cell. Biol. 1999, 19, 7138-7146
20. Ivanov, V. N.; Krasilnikov, M.; Ronai, Z. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling J. Biol. Chem. 2002, 277, 4932-4944
21. Kunigal, S.; Lakka, S. S.; Sodadasu, P. K.; Estes, N.; Rao, J. S. Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer Int. J. Oncol. 2009, 34, 1209-1220
22. Fischer, P.; Hilfiker-Kleiner, D. Survival pathways in hypertrophy and heart failure: the gp130-STAT axis Basic Res. Cardiol. 2007, 102, 393-411
23. Yamamoto, T.; Sekine, Y.; Kashima, K.; Kubota, A.; Sato, N.; Aoki, N.; Matsuda, T. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation Biochem. Biophys. Res. Commun. 2002, 297, 811-817
24. Muromoto, R.; Sekine, Y.; Imoto, S.; Ikeda, O.; Okayama, T.; Sato, N.; Matsuda, T. BART is essential for nuclear retention of STAT3 Int. Immunol. 2008, 20, 395-403
25. Hirano, T.; Nakajima, K.; Hibi, M. Signaling mechanisms through gp130: a model of the cytokine system Cytokine Growth Factor Rev. 1997, 8, 241-252
26. Bousquet, C.; Susini, C.; Melmed, S. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor J. Clin. Invest. 1999, 104, 1277-1285
27. Kim, H.; Baumann, H. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells Mol. Cell. Biol. 1999, 19, 5326-5338
28. Naka, T.; Narazaki, M.; Hirata, M.; Matsumoto, T.; Minamoto, S.; Aono, A.; Nishimoto, N.; Kajita, T.; Taga, T.; Yoshizaki, K.; Akira, S.; Kishimoto, T. Structure and function of a new STAT-induced STAT inhibitor Nature 1997, 387, 924-929
29. Herrmann, A.; Vogt, M.; Monnigmann, M.; Clahsen, T.; Sommer, U.; Haan, S.; Poli, V.; Heinrich, P. C.; Muller-Newen, G. Nucleocytoplasmic shuttling of persistently activated STAT3 J. Cell Sci. 2007, 120, 3249-3261
30. Junicho, A.; Matsuda, T.; Yamamoto, T.; Kishi, H.; Korkmaz, K.; Saatcioglu, F.; Fuse, H.; Muraguchi, A. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells Biochem. Biophys. Res. Commun. 2000, 278, 9-13
31. Zhang, X.; Guo, A.; Yu, J.; Possemato, A.; Chen, Y.; Zheng, W.; Polakiewicz, R. D.; Kinzler, K. W.; Vogelstein, B.; Velculescu, V. E.; Wang, Z. J. Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 4060-4064
32. Yu, H.; Jove, R. The STATs of cancer - new molecular targets come of age Nat. Rev. Cancer 2004, 4, 97-105
33. Bromberg, J. F.; Wrzeszczynska, M. H.; Devgan, G.; Zhao, Y.; Pestell, R. G.; Albanese, C.; Darnell, J. E., Jr. Stat3 as an oncogene Cell 1999, 98, 295-303
34. Li, G. H.; Wei, H.; Lv, S. Q.; Ji, H.; Wang, D. L. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells Int. J. Oncol. 2010, 37, 103-110
35. Kortylewski, M.; Yu, H. Stat3 as a potential target for cancer immunotherapy J. Immunother. 2007, 30, 131-139
36. Wang, T.; Niu, G.; Kortylewski, M.; Burdelya, L.; Shain, K.; Zhang, S.; Bhattacharya, R.; Gabrilovich, D.; Heller, R.; Coppola, D.; Dalton, W.; Jove, R.; Pardoll, D.; Yu, H. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nat. Med. 2004, 10, 48-54
37. Obana, M.; Maeda, M.; Takeda, K.; Hayama, A.; Mohri, T.; Yamashita, T.; Nakaoka, Y.; Komuro, I.; Matsumiya, G.; Azuma, J.; Fujio, Y. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction Circulation 2010, 121, 684-691
38. Hilfiker-Kleiner, D.; Kaminski, K.; Podewski, E.; Bonda, T.; Schaefer, A.; Sliwa, K.; Forster, O.; Quint, A.; Landmesser, U.; Doerries, C.; Luchtefeld, M.; Poli, V.; Schneider, M. D.; Balligand, J. L.; Desjardins, F.; Ansari, A.; Struman, I.; Nguyen, N. Q.; Zschemisch, N. H.; Klein, G.; Heusch, G.; Schulz, R.; Hilfiker, A.; Drexler, H. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy Cell 2007, 128, 589-600
39. Krause, A.; Scaletta, N.; Ji, J. D.; Ivashkiv, L. B. Rheumatoid arthritis synoviocyte survival is dependent on Stat3 J. Immunol. 2002, 169, 6610-6616
40. Shouda, T.; Yoshida, T.; Hanada, T.; Wakioka, T.; Oishi, M.; Miyoshi, K.; Komiya, S.; Kosai, K.; Hanakawa, Y.; Hashimoto, K.; Nagata, K.; Yoshimura, A. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis J. Clin. Invest. 2001, 108, 1781-1788
41. Hirano, T. Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir Proc. Jpn. Acad., Ser. B: Phys. Biol. Sci. 2010, 86, 717-730
42. Wan, J.; Fu, A. K.; Ip, F. C.; Ng, H. K.; Hugon, J.; Page, G.; Wang, J. H.; Lai, K. O.; Wu, Z.; Ip, N. Y. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease J. Neurosci. 2010, 30, 6873-6881
43. Yamada, M.; Chiba, T.; Sasabe, J.; Terashita, K.; Aiso, S.; Matsuoka, M. Nasal colivelin treatment ameliorates memory impairment related to Alzheimer's disease Neuropsychopharmacology 2008, 33, 2020-2032
44. Kuratsune, M.; Masaki, T.; Hirai, T.; Kiribayashi, K.; Yokoyama, Y.; Arakawa, T.; Yorioka, N.; Kohno, N. Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction Nephrology 2007, 12, 565-571
45. Pang, M.; Ma, L.; Gong, R.; Tolbert, E.; Mao, H.; Ponnusamy, M.; Chin, Y. E.; Yan, H.; Dworkin, L. D.; Zhuang, S. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy Kidney Int. 2010, 78, 257-268
46. Huang, Y. H.; Chuang, J. H.; Yang, Y. L.; Huang, C. C.; Wu, C. L.; Chen, C. L. Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling Lab. Invest. 2009, 89, 1128-1139
47. Mair, M.; Zollner, G.; Schneller, D.; Musteanu, M.; Fickert, P.; Gumhold, J.; Schuster, C.; Fuchsbichler, A.; Bilban, M.; Tauber, S.; Esterbauer, H.; Kenner, L.; Poli, V.; Blaas, L.; Kornfeld, J. W.; Casanova, E.; Mikulits, W.; Trauner, M.; Eferl, R. Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis Gastroenterology 2010, 138, 2499-2508
48. Tripathi, S. S.; Mishra, V.; Shukla, M.; Verma, M.; Chaudhury, B. P.; Kumar, P.; Chhabra, J. K.; Pandey, H. P.; Paul, B. IL-6 receptor-mediated lung Th2 cytokine networking in silica-induced pulmonary fibrosis Arch. Toxicol. 2010, 84, 947-955
49. Gao, H.; Ward, P. A. STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses Expert Opin. Ther. Targets 2007, 11, 869-880
50. Qu, P.; Roberts, J.; Li, Y.; Albrecht, M.; Cummings, O. W.; Eble, J. N.; Du, H.; Yan, C. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease Lung Cancer 2009, 63, 341-347
51. Dauer, D. J.; Ferraro, B.; Song, L.; Yu, B.; Mora, L.; Buettner, R.; Enkemann, S.; Jove, R.; Haura, E. B. Stat3 regulates genes common to both wound healing and cancer Oncogene 2005, 24, 3397-3408
52. Sano, S.; Chan, K. S.; Carbajal, S.; Clifford, J.; Peavey, M.; Kiguchi, K.; Itami, S.; Nickoloff, B. J.; DiGiovanni, J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model Nat. Med. 2005, 11, 43-49
53. Romanowska, M.; Reilly, L.; Palmer, C. N.; Gustafsson, M. C.; Foerster, J. Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo PLoS One 2010, 5, e9701
54. Neufert, C.; Pickert, G.; Zheng, Y.; Wittkopf, N.; Warntjen, M.; Nikolaev, A.; Ouyang, W.; Neurath, M. F.; Becker, C. Activation of epithelial STAT3 regulates intestinal homeostasis Cell Cycle 2010, 9, 652-655
55. Carey, R.; Jurickova, I.; Ballard, E.; Bonkowski, E.; Han, X.; Xu, H.; Denson, L. A. Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease Inflamm. Bowel Dis. 2008, 14, 446-457
56. Bai, A.; Hu, P.; Chen, J.; Song, X.; Chen, W.; Peng, W.; Zeng, Z.; Gao, X. Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis Int. J. Colorectal Dis. 2007, 22, 625-635
57. Bates, S. H.; Stearns, W. H.; Dundon, T. A.; Schubert, M.; Tso, A. W.; Wang, Y.; Banks, A. S.; Lavery, H. J.; Haq, A. K.; Maratos-Flier, E.; Neel, B. G.; Schwartz, M. W.; Myers, M. G., Jr. STAT3 signalling is required for leptin regulation of energy balance but not reproduction Nature 2003, 421, 856-859
58. Puglianiello, A.; Germani, D.; Cianfarani, S. Exposure to uteroplacental insufficiency reduces the expression of signal transducer and activator of transcription 3 and proopiomelanocortin in the hypothalamus of newborn rats Pediatr. Res. 2009, 66, 208-211
59. Wang, P.; Yang, F. J.; Du, H.; Guan, Y. F.; Xu, T. Y.; Xu, X. W.; Su, D. F.; Miao, C. Y. Involvement of leptin receptor (LepRb)-STAT3 signaling pathway in brain FTO downregulation during energy restriction Mol. Med. 2011, 17, 523-532
60. Gharavi, N. M.; Alva, J. A.; Mouillesseaux, K. P.; Lai, C.; Yeh, M.; Yeung, W.; Johnson, J.; Szeto, W. L.; Hong, L.; Fishbein, M.; Wei, L.; Pfeffer, L. M.; Berliner, J. A. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo J. Biol. Chem. 2007, 282, 31460-31468
61. Khan, J. A.; Cao, M.; Kang, B. Y.; Liu, Y.; Mehta, J. L.; Hermonat, P. L. AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol Atherosclerosis 2010, 213, 59-66
62. Zhou, X.; Li, D.; Yan, W.; Li, W. Pravastatin prevents aortic atherosclerosis via modulation of signal transduction and activation of transcription 3 (STAT3) to attenuate interleukin-6 (IL-6) action in ApoE knockout mice Int. J. Mol. Sci. 2008, 9, 2253-2264
63. Niwa, H.; Ogawa, K.; Shimosato, D.; Adachi, K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells Nature 2009, 460, 118-122
64. Boiani, M.; Scholer, H. R. Regulatory networks in embryo-derived pluripotent stem cells Nat. Rev. Mol. Cell Biol. 2005, 6, 872-884
65. Torres, J.; Watt, F. M. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3 Nat. Cell Biol. 2008, 10, 194-201
66. Setati, M. M.; Prinsloo, E.; Longshaw, V. M.; Murray, P. A.; Edgar, D. H.; Blatch, G. L. Leukemia inhibitory factor promotes Hsp90 association with STAT3 in mouse embryonic stem cells IUBMB Life 2010, 62, 61-66
67. Ying, Q. L.; Nichols, J.; Chambers, I.; Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3 Cell 2003, 115, 281-292
68. Boyer, L. A.; Mathur, D.; Jaenisch, R. Molecular control of pluripotency Curr. Opin. Genet. Dev. 2006, 16, 455-462
69. Yang, J.; van Oosten, A. L.; Theunissen, T. W.; Guo, G.; Silva, J. C.; Smith, A. Stat3 activation is limiting for reprogramming to ground state pluripotency Cell Stem Cell 2010, 7, 319-328
70. Humphrey, R. K.; Beattie, G. M.; Lopez, A. D.; Bucay, N.; King, C. C.; Firpo, M. T.; Rose-John, S.; Hayek, A. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent Stem Cells 2004, 22, 522-530
71. Daheron, L.; Opitz, S. L.; Zaehres, H.; Lensch, M. W.; Andrews, P. W.; Itskovitz-Eldor, J.; Daley, G. Q. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells Stem Cells 2004, 22, 770-778
72. Chung, Y. J.; Park, B. B.; Kang, Y. J.; Kim, T. M.; Eaves, C. J.; Oh, I. H. Unique effects of Stat3 on the early phase of hematopoietic stem cell regeneration Blood 2006, 108, 1208-1215
73. Onai, N.; Manz, M. G. The STATs on dendritic cell development Immunity 2008, 28, 490-492
74. Chou, W. C.; Levy, D. E.; Lee, C. K. STAT3 positively regulates an early step in B-cell development Blood 2006, 108, 3005-3011
75. Oatley, J. M.; Kaucher, A. V.; Avarbock, M. R.; Brinster, R. L. Regulation of mouse spermatogonial stem cell differentiation by STAT3 signaling Biol. Reprod. 2010, 83, 427-433
76. Yang, Y.; Xu, Y.; Li, W.; Wang, G.; Song, Y.; Yang, G.; Han, X.; Du, Z.; Sun, L.; Ma, K. STAT3 induces muscle stem cell differentiation by interaction with myoD Cytokine 2009, 46, 137-141
77. Deng, J.; Grande, F.; Neamati, N. Small molecule inhibitors of Stat3 signaling pathway Curr. Cancer Drug Targets 2007, 7, 91-107
78. Zhao, M.; Jiang, B.; Gao, F. H. Small molecule inhibitors of STAT3 for cancer therapy Curr. Med. Chem. 2011, 18, 4012-4018
79. Mankan, A. K.; Greten, F. R. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors Expert Opin. Invest. Drugs 2011, 20, 1263-1275
80. Lavecchia, A.; Di Giovanni, C.; Novellino, E. STAT-3 inhibitors: state of the art and new horizons for cancer treatment Curr. Med. Chem. 2011, 18, 2359-2375
81. Page, B. D.; Ball, D. P.; Gunning, P. T. Signal transducer and activator of transcription 3 inhibitors: a patent review Expert Opin. Ther. Pat. 2011, 21, 65-83
82. Uehara, Y.; Mochizuki, M.; Matsuno, K.; Haino, T.; Asai, A. Novel high-throughput screening system for identifying STAT3-SH2 antagonists Biochem. Biophys. Res. Commun. 2009, 380, 627-631
83. Song, H.; Wang, R.; Wang, S.; Lin, J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 4700-4705
84. Siddiquee, K.; Zhang, S.; Guida, W. C.; Blaskovich, M. A.; Greedy, B.; Lawrence, H. R.; Yip, M. L.; Jove, R.; McLaughlin, M. M.; Lawrence, N. J.; Sebti, S. M.; Turkson, J. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 7391-7396
85. Gunning, P. T.; Glenn, M. P.; Siddiquee, K. A.; Katt, W. P.; Masson, E.; Sebti, S. M.; Turkson, J.; Hamilton, A. D. Targeting protein-protein interactions: suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain binders ChemBioChem 2008, 9, 2800-2803
86. Zhang, X.; Yue, P.; Fletcher, S.; Zhao, W.; Gunning, P. T.; Turkson, J. A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes Biochem. Pharmacol. 2010, 79, 1398-1409
87. Li, H.; Liu, A.; Zhao, Z.; Xu, Y.; Lin, J.; Jou, D.; Li, C. Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3) J. Med. Chem. 2011, 54, 5592-5596
88. Dann, M.; Lefemine, D. V.; Barbatschi, F.; Shu, P.; Kunstmann, M. P.; Mitscher, L. A.; Bohonos, N. Tetrangomycin, a new quinone antibiotic Antimicrob. Agents Chemother. 1965, 5, 832-835
89. Bhasin, D.; Cisek, K.; Pandharkar, T.; Regan, N.; Li, C.; Pandit, B.; Lin, J.; Li, P. K. Design, synthesis, and studies of small molecule STAT3 inhibitors Bioorg. Med. Chem. Lett. 2008, 18, 391-395
90. Lin, L.; Hutzen, B.; Li, P. K.; Ball, S.; Zuo, M.; DeAngelis, S.; Foust, E.; Sobo, M.; Friedman, L.; Bhasin, D.; Cen, L.; Li, C.; Lin, J. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells Neoplasia 2010, 12, 39-50
91. Song, H.; Wang, R.; Wang, S.; Lin, J. Small Molecule Inhibitors of Stat3 and the Uses Thereof. WO 2006/091837 A2, 2006.
92. Fuh, B.; Sobo, M.; Cen, L.; Josiah, D.; Hutzen, B.; Cisek, K.; Bhasin, D.; Regan, N.; Lin, L.; Chan, C.; Caldas, H.; DeAngelis, S.; Li, C.; Li, P. K.; Lin, J. LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model Br. J. Cancer 2009, 100, 106-112
93. Mencalha, A. L.; Du Rocher, B.; Salles, D.; Binato, R.; Abdelhay, E. LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of imatinib mesylate Cancer Chemother. Pharmacol. 2010, 65, 1039-1046
94. Ball, S.; Li, C.; Li, P. K.; Lin, J. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells PLoS One 2011, 6, e18820
95. Schust, J.; Sperl, B.; Hollis, A.; Mayer, T. U.; Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization Chem. Biol. 2006, 13, 1235-1242
96. Villalva, C.; Martin-Lanneree, S.; Cortes, U.; Dkhissi, F.; Wager, M.; Le Corf, A.; Tourani, J. M.; Dusanter-Fourt, I.; Turhan, A. G.; Karayan-Tapon, L. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy? Int. J. Cancer 2011, 128, 826-838
97. Friedman, L.; Lin, L.; Ball, S.; Bekaii-Saab, T.; Fuchs, J.; Li, P. K.; Li, C.; Lin, J. Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells Anti-Cancer Drugs 2009, 20, 444-449
98. Lin, L.; Hutzen, B.; Ball, S.; Foust, E.; Sobo, M.; Deangelis, S.; Pandit, B.; Friedman, L.; Li, C.; Li, P. K.; Fuchs, J.; Lin, J. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells Cancer Sci. 2009, 100, 1719-1727
99. Lin, L.; Hutzen, B.; Zuo, M.; Ball, S.; Deangelis, S.; Foust, E.; Pandit, B.; Ihnat, M. A.; Shenoy, S. S.; Kulp, S.; Li, P. K.; Li, C.; Fuchs, J.; Lin, J. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells Cancer Res. 2010, 70, 2445-2454
100. Lin, L.; Deangelis, S.; Foust, E.; Fuchs, J.; Li, C.; Li, P. K.; Schwartz, E. B.; Lesinski, G. B.; Benson, D.; Lu, J.; Hoyt, D.; Lin, J. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells Mol. Cancer 2010, 9, 217
101. Bill, M. A.; Fuchs, J. R.; Li, C.; Yui, J.; Bakan, C.; Benson, D. M., Jr.; Schwartz, E. B.; Abdelhamid, D.; Lin, J.; Hoyt, D. G.; Fossey, S. L.; Young, G. S.; Carson, W. E., 3rd; Li, P. K.; Lesinski, G. B. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity Mol. Cancer 2010, 9, 165
102. Xu, J.; Cole, D. C.; Chang, C. P.; Ayyad, R.; Asselin, M.; Hao, W.; Gibbons, J.; Jelinsky, S. A.; Saraf, K. A.; Park, K. Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters J. Med. Chem. 2008, 51, 4115-4121
103. Lin, L.; Amin, R.; Gallicano, G. I.; Glasgow, E.; Jogunoori, W.; Jessup, J. M.; Zasloff, M.; Marshall, J. L.; Shetty, K.; Johnson, L.; Mishra, L.; He, A. R. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling Oncogene 2009, 28, 961-972
104. Fletcher, S.; Singh, J.; Zhang, X.; Yue, P.; Page, B. D.; Sharmeen, S.; Shahani, V. M.; Zhao, W.; Schimmer, A. D.; Turkson, J.; Gunning, P. T. Disruption of transcriptionally active Stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities ChemBioChem 2009, 10, 1959-1964
105. Fletcher, S.; Page, B. D.; Zhang, X.; Yue, P.; Li, Z. H.; Sharmeen, S.; Singh, J.; Zhao, W.; Schimmer, A. D.; Trudel, S.; Turkson, J.; Gunning, P. T. Antagonism of the Stat3-Stat3 protein dimer with salicylic acid based small molecules ChemMedChem 2011, 6, 1459-1470
106. Page, B. D.; Fletcher, S.; Yue, P.; Li, Z.; Zhang, X.; Sharmeen, S.; Datti, A.; Wrana, J. L.; Trudel, S.; Schimmer, A. D.; Turkson, J.; Gunning, P. T. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain Bioorg. Med. Chem. Lett. 2011, 21, 5605-5609
107. Frank, D. A. STAT Modulators. WO 2008/156644 A2, 2008.
108. Nelson, E. A.; Walker, S. R.; Kepich, A.; Gashin, L. B.; Hideshima, T.; Ikeda, H.; Chauhan, D.; Anderson, K. C.; Frank, D. A. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3 Blood 2008, 112, 5095-5102
109. Xu, X.; Kasembeli, M. M.; Jiang, X.; Tweardy, B. J.; Tweardy, D. J. Chemical probes that competitively and selectively inhibit Stat3 activation PLoS One 2009, 4, e4783
110. Redell, M. S.; Ruiz, M. J.; Alonzo, T. A.; Gerbing, R. B.; Tweardy, D. J. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor Blood 2011, 117, 5701-5709
111. Matsuno, K.; Masuda, Y.; Uehara, Y.; Sato, H.; Muroya, A.; Takahashi, O.; Yokotagawa, T.; Furuya, T.; Okawara, T.; Otsuka, M.; Ogo, N.; Ashizawa, T.; Oshita, C.; Tai, S.; Ishii, H.; Akiyama, Y.; Asai, A. Identification of a New Series of STAT3 Inhibitors by Virtual Screening ACS Med. Chem. Lett. 2010, 1, 371-375
112. Shin, D. S.; Kim, H. N.; Shin, K. D.; Yoon, Y. J.; Kim, S. J.; Han, D. C.; Kwon, B. M. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells Cancer Res. 2009, 69, 193-202
113. Kim, N. H.; Lee, M. Y.; Park, S. J.; Choi, J. S.; Oh, M. K.; Kim, I. S. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3 Immunology 2007, 122, 607-614
114. Cuevas, P.; Diaz-Gonzalez, D.; Sanchez, I.; Lozano, R. M.; Gimenez-Gallego, G.; Dujovny, M. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells Neurol. Res. 2006, 28, 127-130
115. Selvendiran, K.; Bratasz, A.; Tong, L.; Ignarro, L. J.; Kuppusamy, P. NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts Cell Cycle 2008, 7, 81-88
116. Dowlati, A.; Kluge, A.; Nethery, D.; Halmos, B.; Kern, J. A. SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2 Anti-Cancer Drugs 2008, 19, 9-16
117. Liby, K.; Voong, N.; Williams, C. R.; Risingsong, R.; Royce, D. B.; Honda, T.; Gribble, G. W.; Sporn, M. B.; Letterio, J. J. The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells Clin. Cancer Res. 2006, 12, 4288-4293
118. Ling, X.; Konopleva, M.; Zeng, Z.; Ruvolo, V.; Stephens, L. C.; Schober, W.; McQueen, T.; Dietrich, M.; Madden, T. L.; Andreeff, M. The novel triterpenoid C-28 methyl ester of 2-cyano-3,12-dioxoolen-1,9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling Cancer Res. 2007, 67, 4210-4218
119. Liu, Y. C.; Hsieh, C. W.; Wu, C. C.; Wung, B. S. Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile Life Sci. 2007, 80, 1420-1430
120. Pandey, M. K.; Sung, B.; Ahn, K. S.; Aggarwal, B. B. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1 Mol. Pharmacol. 2009, 75, 525-533
121. Agarwal, C.; Tyagi, A.; Kaur, M.; Agarwal, R. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells Carcinogenesis 2007, 28, 1463-1470
122. Bhutani, M.; Pathak, A. K.; Nair, A. S.; Kunnumakkara, A. B.; Guha, S.; Sethi, G.; Aggarwal, B. B. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation Clin. Cancer Res. 2007, 13, 3024-3032
123. Pathak, A. K.; Bhutani, M.; Nair, A. S.; Ahn, K. S.; Chakraborty, A.; Kadara, H.; Guha, S.; Sethi, G.; Aggarwal, B. B. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells Mol. Cancer Res. 2007, 5, 943-955
124. Pandey, M. K.; Sung, B.; Aggarwal, B. B. Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells Int. J. Cancer 2010, 127, 282-292
125. Ahn, K. S.; Sethi, G.; Sung, B.; Goel, A.; Ralhan, R.; Aggarwal, B. B. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1 Cancer Res. 2008, 68, 4406-4415
126. Sandur, S. K.; Pandey, M. K.; Sung, B.; Aggarwal, B. B. 5-Hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization Mol. Cancer Res. 2010, 8, 107-118
127. Kannappan, R.; Yadav, V. R.; Aggarwal, B. B. γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents J. Biol. Chem. 2010, 285, 33520-33528
128. Sun, M.; Liu, C.; Nadiminty, N.; Lou, W.; Zhu, Y.; Yang, J.; Evans, C. P.; Zhou, Q.; Gao, A. C. Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion Prostate 2012, 72, 82-89
129. Duan, Z.; Bradner, J. E.; Greenberg, E.; Levine, R.; Foster, R.; Mahoney, J.; Seiden, M. V. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation Clin. Cancer Res. 2006, 12, 6844-6852
130. Muto, A.; Hori, M.; Sasaki, Y.; Saitoh, A.; Yasuda, I.; Maekawa, T.; Uchida, T.; Asakura, K.; Nakazato, T.; Kaneda, T.; Kizaki, M.; Ikeda, Y.; Yoshida, T. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor Mol. Cancer Ther. 2007, 6, 987-994
131. Liu, L.; Nam, S.; Tian, Y.; Yang, F.; Wu, J.; Wang, Y.; Scuto, A.; Polychronopoulos, P.; Magiatis, P.; Skaltsounis, L.; Jove, R. 6-Bromoindirubin-3a-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells Cancer Res. 2011, 71, 3972-3979
132. Park, E. J.; Kim, S. A.; Choi, Y. M.; Kwon, H. K.; Shim, W.; Lee, G.; Choi, S. Capric acid inhibits NO production and STAT3 activation during LPS-induced osteoclastogenesis PLoS One 2011, 6, e27739
133. Walker, S. R.; Chaudhury, M.; Frank, D. A. STAT3 inhibition by microtubule-targeted drugs: dual molecular effects of chemotherapeutic agents Mol. Cell. Pharmacol. 2011, 3, 13-19
134. Ren, Z.; Cabell, L. A.; Schaefer, T. S.; McMurray, J. S. Identification of a high-affinity phosphopeptide inhibitor of Stat3 Bioorg. Med. Chem. Lett. 2003, 13, 633-636
135. Coleman, D. R. t.; Ren, Z.; Mandal, P. K.; Cameron, A. G.; Dyer, G. A.; Muranjan, S.; Campbell, M.; Chen, X.; McMurray, J. S. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor J. Med. Chem. 2005, 48, 6661-6670
136. Gomez, C.; Bai, L.; Zhang, J.; Nikolovska-Coleska, Z.; Chen, J.; Yi, H.; Wang, S. Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors Bioorg. Med. Chem. Lett. 2009, 19, 1733-1736
137. Chen, J.; Bai, L.; Bernard, D.; Nikolovska-Coleska, Z.; Gomez, C.; Zhang, J.; Yi, H.; Wang, S. Structure-based design of conformationally constrained, cell-permeable STAT3 inhibitors ACS Med. Chem. Lett. 2010, 1, 85-89
138. Mandal, P. K.; Ren, Z.; Chen, X.; Xiong, C.; McMurray, J. S. Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3 J. Med. Chem. 2009, 52, 6126-6141
139. Siddiquee, K. A.; Gunning, P. T.; Glenn, M.; Katt, W. P.; Zhang, S.; Schrock, C.; Sebti, S. M.; Jove, R.; Hamilton, A. D.; Turkson, J. An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects ACS Chem. Biol. 2007, 2, 787-798
140. Turkson, J.; Hamilton, A. D.; Jove, R.; Sebti, S. M. Stat3 Inhibitor Having Anti-Cancer Activity and Associated Methods. WO 2008/070697 A2, 2008.
141. Shahani, V. M.; Yue, P.; Fletcher, S.; Sharmeen, S.; Sukhai, M. A.; Luu, D. P.; Zhang, X.; Sun, H.; Zhao, W.; Schimmer, A. D.; Turkson, J.; Gunning, P. T. Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein Bioorg. Med. Chem. 2011, 19, 1823-1838
142. NCT01047943. Intrapatient Comparison Study of Efficacy of STA-21 Ointment on Psoriatic Skin Lesions. http://clinicaltrials.gov.
143. NCT01066663. A Phase I/II Study of Pyrimethamine, a STAT3 Inhibitor, for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. http://clinicaltrials.gov.
144. NCT00955812. A Phase I, Open-label, Dose Escalation, Non-randomized Study To Assess the Pharmacokinetics, Dose Limiting Toxicity, and Maximum Tolerated Dose of OPB-31121 in Subjects with Advanced Solid Tumors. http://clinicaltrials. gov.
145. NCT00529113. A Randomized Phase I/II Study with Gemcitabine and RTA 402 or Gemcitabine and Placebo for Patients with Unresectable Pancreatic Cancer. http://clinicaltrials.gov.
146. Hong, D. S.; Kurzrock, R.; Supko, J. G.; Lawrence, D. P.; Wheler, J. J.; Meyer, C. J.; Mier, J. W.; Andreeff, M.; Shapiro, G. I.; Dezube, B. J. Phase I trial with a novel oral NF-κB/STAT3 inhibitor RTA 402 in patients with solid tumors and lymphoid malignancies J. Clin. Oncol. 2008, 26 (15S) 3517
147. Al Zaid Siddiquee, K.; Turkson, J. STAT3 as a target for inducing apoptosis in solid and hematological tumors Cell Res. 2008, 18, 254-267
148. Bowman, T.; Garcia, R.; Turkson, J.; Jove, R. STATs in oncogenesis
149. Buettner, R.; Mora, L. B.; Jove, R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention Clin. Cancer Res. 2002, 8, 945-954
150. Chen, C. L.; Hsieh, F. C.; Lieblein, J. C.; Brown, J.; Chan, C.; Wallace, J. A.; Cheng, G.; Hall, B. M.; Lin, J. Stat3 activation in human endometrial and cervical cancers Br. J. Cancer 2007, 96, 591-599
151. Cheng, G. Z.; Zhang, W. Z.; Sun, M.; Wang, Q.; Coppola, D.; Mansour, M.; Xu, L. M.; Costanzo, C.; Cheng, J. Q.; Wang, L. H. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function J. Biol. Chem. 2008, 283, 14665-14673
152. Duan, Z.; Foster, R.; Bell, D. A.; Mahoney, J.; Wolak, K.; Vaidya, A.; Hampel, C.; Lee, H.; Seiden, M. V. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer Clin. Cancer Res. 2006, 12, 5055-5063
153. Abdulghani, J.; Gu, L.; Dagvadorj, A.; Lutz, J.; Leiby, B.; Bonuccelli, G.; Lisanti, M. P.; Zellweger, T.; Alanen, K.; Mirtti, T.; Visakorpi, T.; Bubendorf, L.; Nevalainen, M. T. Stat3 promotes metastatic progression of prostate cancer Am. J. Pathol. 2008, 172, 1717-1728
154. Corvinus, F. M.; Orth, C.; Moriggl, R.; Tsareva, S. A.; Wagner, S.; Pfitzner, E. B.; Baus, D.; Kaufmann, R.; Huber, L. A.; Zatloukal, K.; Beug, H.; Ohlschlager, P.; Schutz, A.; Halbhuber, K. J.; Friedrich, K. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth Neoplasia 2005, 7, 545-555
155. Dhir, R.; Ni, Z.; Lou, W.; DeMiguel, F.; Grandis, J. R.; Gao, A. C. Stat3 activation in prostatic carcinomas Prostate 2002, 51, 241-246
156. Guo, C.; Yang, G.; Khun, K.; Kong, X.; Levy, D.; Lee, P.; Melamed, J. Activation of Stat3 in renal tumors Am. J. Transl. Res. 2009, 1, 283-290
157. Schaefer, L. K.; Ren, Z.; Fuller, G. N.; Schaefer, T. S. Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2) Oncogene 2002, 21, 2058-2065
158. Seki, Y.; Suzuki, N.; Imaizumi, M.; Iwamoto, T.; Usami, N.; Ueda, Y.; Hamaguchi, M. STAT3 and MAPK in human lung cancer tissues and suppression of oncogenic growth by JAB and dominant negative STAT3 Int. J. Oncol. 2004, 24, 931-934
159. Wei, D.; Le, X.; Zheng, L.; Wang, L.; Frey, J. A.; Gao, A. C.; Peng, Z.; Huang, S.; Xiong, H. Q.; Abbruzzese, J. L.; Xie, K. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis Oncogene 2003, 22, 319-329
160. Abou-Ghazal, M.; Yang, D. S.; Qiao, W.; Reina-Ortiz, C.; Wei, J.; Kong, L. Y.; Fuller, G. N.; Hiraoka, N.; Priebe, W.; Sawaya, R.; Heimberger, A. B. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas Clin. Cancer Res. 2008, 14, 8228-8235
161. Grandis, J. R.; Drenning, S. D.; Zeng, Q.; Watkins, S. C.; Melhem, M. F.; Endo, S.; Johnson, D. E.; Huang, L.; He, Y.; Kim, J. D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 4227-4232
162. Schuringa, J. J.; Wierenga, A. T.; Kruijer, W.; Vellenga, E. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6 Blood 2000, 95, 3765-3770
163. Turkson, J. STAT proteins as novel targets for cancer drug discovery Expert Opin. Ther. Targets 2004, 8, 409-422
164. Xie, T. X.; Huang, F. J.; Aldape, K. D.; Kang, S. H.; Liu, M.; Gershenwald, J. E.; Xie, K.; Sawaya, R.; Huang, S. Activation of stat3 in human melanoma promotes brain metastasis Cancer Res. 2006, 66, 3188-3196
165. Zamo, A.; Chiarle, R.; Piva, R.; Howes, J.; Fan, Y.; Chilosi, M.; Levy, D. E.; Inghirami, G. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death Oncogene 2002, 21, 1038-1047
166. Sano, S.; Chan, K. S.; DiGiovanni, J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases J. Dermatol. Sci. 2008, 50, 1-14
167. Liu, H.; Moroi, Y.; Yasumoto, S.; Kokuba, H.; Imafuku, S.; Nakahara, T.; Dainichi, T.; Uchi, H.; Tu, Y.; Furue, M.; Urabe, K. Immunohistochemical localization of activated Stat3 and hTERT protein in psoriasis vulgaris Eur. J. Dermatol. 2006, 16, 205-207
168. Turkson, J.; Gunning, P. Compounds That Suppress Cancer Cells and Exhibit Antitumor Activity. WO2010117438 (A2), 2010.
169. Turkson, J.; Hamilton, A. D. Inhibitors of STAT3. WO 2010/033685 A1, 2010.
170. Kupershmidt, I.; Su, Q. J.; Grewal, A.; Sundaresh, S.; Halperin, I.; Flynn, J.; Shekar, M.; Wang, H.; Park, J.; Cui, W.; Wall, G. D.; Wisotzkey, R.; Alag, S.; Akhtari, S.; Ronaghi, M. Ontology-based meta-analysis of global collections of high-throughput public data PLoS One 2010, 5 e13066
171. Tanguy Le Carrour, S. A.; Tondeur, S.; Lhermitte, L.; Lamb, N.; Reme, T.; Pantesco, V.; Hamamah, S.; Klein, B.; De Vos, J. Amazonia!: an online resource to google and visualize public human whole genome expression data Open Bioinf. J. 2010, 4, 5-10
172. Wu, C.; Orozco, C.; Boyer, J.; Leglise, M.; Goodale, J.; Batalov, S.; Hodge, C. L.; Haase, J.; Janes, J.; Huss, J. W., 3rd; Su, A. I. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources Genome Biol. 2009, 10, R130